Cas3 is a limiting factor for CRISPR-Cas immunity in Escherichia coli cells lacking H-NS

QR Code

Cas3 is a limiting factor for CRISPR-Cas immunity in Escherichia coli cells lacking H-NS

Background: CRISPR-Cas systems provide adaptive immunity to mobile genetic elements in prokaryotes. In many bacteria, including E. coli, a specialized ribonucleoprotein complex called Cascade enacts immunity by “an interference reaction" between CRISPR encoded RNA (crRNA) and invader DNA sequen...

Full description

Bibliographic Details
Main Authors:	Majsec, Kristina, Bolt, Edward L., Ivančić-Baće, Ivana
Format:	Article
Published:	BioMed Central 2016
Subjects:	CRISPR-Cas H-NS PAM HtpG Temperature E. coli
Online Access:	https://eprints.nottingham.ac.uk/35111/

Similar Items

Characterising Host Factors Required for CRISPR Cas Adaptation in Escherichia coli
by: Edwards, Harry
Published: (2023)

Investigation of CRISPR-Cas adaptation mechanism through exploration of Cas4-1 fusions
by: Walker, Emily
Published: (2019)

CRISPR-Cas9-mediated genome editing of the extracellular matrix gene TNC in human fibroblasts
by: Brunetti, Giulio
Published: (2017)

Molecular insights into DNA interference by CRISPR-associated nuclease-helicase Cas3
by: Gong, Bei, et al.
Published: (2014)

CRISPR-Cas immunity: analysis of adaptation and interference reactions in prokaryotes
by: Cass, S.D.B.
Published: (2016)

The role of Cas8 in type I CRISPR interference
by: Cass, Simon, et al.
Published: (2015)

Analysis of the E. coli CRISPR Cas3 protein and its potential for regulation by a short non-coding RNA
by: Kennerdale, Niamh
Published: (2024)

Analysis of Cas1-2 and Cas3 CRISPR immunity proteins in E. coli cell physiology
by: Reeves, Ryan Peter
Published: (2019)

CRISPR-Cas9 gene targeting of human induced pluripotent stem cells to generate a palette of optical reporter cell lines towards investigating hypertrophic cardiomyopathy
by: Bhagwan, Jamie R.
Published: (2018)

Genetic screens in intestinal organoid (mini-gut) culture using CRISPR-Cas-9 System and studying the role of FBXL5 in colorectal cancer cells
by: Jinks, Nicholas
Published: (2022)

Applications of a high-throughput screen detecting CRISPR-Cas spacer acquisition
by: Cannon, Christopher
Published: (2025)

Simplified footprint-free Cas9/CRISPR editing of cardiac-associated genes in human pluripotent stem cells
by: Kondrashov, Alexander, et al.
Published: (2018)

Different genome stability proteins underpin primed and naïve adaptation in E. coli CRISPR-Cas immunity
by: Ivančić-Baće, Ivana, et al.
Published: (2015)

CRISPR-Cas Adaptation in Escherichia coli requires RecBCD helicase but not nuclease activity, is independent of homologous recombination, and is antagonised by 5’ ssDNA exonucleases
by: Killelea, Tom, et al.
Published: (2018)

Optimized inducible shRNA and CRISPR/Cas9 platforms for in vitro studies of human development using hPSCs
by: Bertero, Alessandro, et al.
Published: (2016)

Gene editing the phytoene desaturase alleles of Cavendish banana using CRISPR/Cas9
by: Eftekhari, Fatima, et al.
Published: (2018)

Disease modeling hypertrophic cardiomyopathy using CRISPR/Cas9 genome editing technology in human pluripotent stem cell-derived cardiomyocytes
by: Mosqueira, Diogo
Published: (2018)

CRISPR/Cas9 editing in human pluripotent stem cell-cardiomyocytes highlights arrhythmias, hypocontractility, and energy depletion as potential therapeutic targets for hypertrophic cardiomyopathy
by: Mosqueira, Diogo, et al.
Published: (2018)

RNA-guided integration of diverse DNA molecules by casposase-Cas9 fusions
by: Lau, Chun H.
Published: (2020)

Part A: Application of fluorescent markers onto CRISPR-associated proteins/ Part B: Substitution of cysteine residues in CRISPR associated Protein Cas1
by: Parr, Lochlan
Published: (2024)

CRISPR systems - molecular mechanisms of the interaction between Cas1 and DnaK
by: Stewart, Alison L.
Published: (2025)

On Cas A, Cassini, comets, and King Charles
by: Soria, Roberto, et al.
Published: (2013)

Acetylation of TBX5 by KAT2B and KAT2A regulates heart and limb development
by: Ghosh, Tushar K., et al.
Published: (2018)

Investigating a human DNA repair helicase that supports CRISPR editing
by: Cubbon, Andrew
Published: (2022)

Cas3 nuclease activity is regulated by an iHDA1 region located at the interface between HD and RecA1 domain
by: He, Liu
Published: (2022)

Analysis of DNA binding and translocation by the E. coli CRISPR immunity protein Cas3
by: He, Liu
Published: (2018)

Harnessing CRISPR-Cas to combat COVID-19: from diagnostics to therapeutics
by: Kok, Gan Chan, et al.
Published: (2021)

CRISPR-Cas knockout of miR21 reduces glioma growth
by: Nieland, Lisa, et al.
Published: (2022)

The enhancement of plant disease resistance using CRISPR/Cas9 technology
by: Mohd Azman, Amier Asyraf, et al.
Published: (2022)

Exploiting acetogenic bacteria for sustainable production of chemicals
by: Poulalier Delavelle, Margaux
Published: (2023)

Combinatorial Crispr/Cas9 For Suppression Of Latent Hiv-1 Provirus In Vitro
by: Ravichantar, Nithya
Published: (2020)

Development of a high-throughput screen for the study of CRISPR spacer acquisition
by: Braithwaite, Jack
Published: (2021)

Molecular Characterisation Of Escherichia Coli Serogroup O 157:H7
by: Mohd Dzomir, Ahmad Zainuri
Published: (1998)

Development of CRISPR-cas9 ribonucleoprotein complex platform for disruption of candidalysin in Candida albicans
by: Ahmad, Hasna, et al.
Published: (2020)

Precision Genome Engineering and Gene Silencing Using CRISPR/dCas9 System
by: Arooj, Mahira
Published: (2018)

The expansion of available bioparts and the development of CRISPR/Cas9 for genetic engineering of Parageobacillus thermoglucosidasius
by: Lau, Matthew Simon Harold
Published: (2019)

CRISPR/dCas9 platforms in plants: strategies and applications beyond genome editing
by: Moradpour, Mahdi, et al.
Published: (2019)

Improvement Of Molecular Methods For Detection Of Pathogenic Escherichia Coli.
by: Abdullah Al-Haj, Nagi Ahmed
Published: (2007)

Molecular Characterisation of Extended Spectrum Beta-Lactamase-Producing Escherichia Coli in Selayang Hospital, Malaysia.
by: Yusof, Rusmah
Published: (2011)

Construction Of Recombinant Escherichia Coli Bad85 For The Production Of High Purity L-Lactic Acid
by: Tengku Zainal Mulok, Tengku Elida
Published: (2008)